{"id":"W3165353358","doi":"10.1136/annrheumdis-2021-eular.1334","title":"AB0538 POOLED SAFETY RESULTS FROM TWO PHASE-3 TRIALS OF GUSELKUMAB IN PATIENTS WITH PSORIATIC ARTHRITIS THROUGH 1 YEAR","year":2021,"lang":"en","type":"article","venue":"Annals of the Rheumatic Diseases","topic":"Pharmaceutical studies and practices","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"Memorial University of Newfoundland","funders":"UCB Pharma; Celgene; Gilead Sciences; Celltrion; Sanofi; Amgen; Pfizer; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Psoriatic arthritis; Tolerability; Adverse effect; Internal medicine; Placebo; Surgery; Arthritis; Alternative medicine; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01157978,0.001836341,0.005388652,0.001467663,0.0004199716,0.001800718,0.0007417423,0.00130717,0.003291689],"category_scores_gemma":[0.0115707,0.0009095667,0.01290084,0.001406231,0.0004481306,0.00177993,0.0009293774,0.002390471,0.0005342687],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001220405,"about_ca_system_score_gemma":0.001461221,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001058463,"about_ca_topic_score_gemma":0.003128139,"domain_scores_codex":[0.9936271,0.003329037,0.001207698,0.0007593989,0.0007082201,0.0003685986],"domain_scores_gemma":[0.9941255,0.002842143,0.001491264,0.0005606278,0.0007007066,0.0002797052],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"meta_analysis","study_design_scores_codex":[0.5746546,0.001038317,0.01677401,0.0129201,0.2495355,0.0002292049,0.000190844,0.003899691,0.006303899,0.000283551,0.004631658,0.1295386],"study_design_scores_gemma":[0.4113688,0.08298711,0.1061658,0.001942746,0.374263,0.0006959668,0.0001694149,0.002425027,0.00420345,0.00160509,0.01397981,0.0001937693],"study_design_candidate":"meta_analysis","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.6982033,0.2662731,0.006388394,0.001938383,0.00203218,0.003610201,0.01167405,0.000489072,0.009391285],"genre_scores_gemma":[0.9669003,0.02096307,0.001823954,0.001750582,0.0006655755,0.001107252,0.004932844,0.00006409155,0.001792346],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.01157978,"threshold_uncertainty_score":0.06124049,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.103935737754341,"score_gpt":0.4082990128892412,"score_spread":0.3043632751349001,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}